Precipio EPS - Earnings per Share 2011-2025 | PRPO
Precipio eps - earnings per share from 2011 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Precipio Annual EPS | |
|---|---|
| 2024 | $-2.93 |
| 2023 | $-4.51 |
| 2022 | $-10.73 |
| 2021 | $-8.00 |
| 2020 | $-17.00 |
| 2019 | $-46.60 |
| 2018 | $-276.40 |
| 2017 | $-2,146.93 |
| 2016 | $-2,830.59 |
| 2015 | $-25,032.53 |
| 2014 | $-18,099.06 |
| 2013 | $-20,710.37 |
| 2012 | $-13,956.99 |
| 2011 | $-23,591.81 |
| 2010 | $-0.06 |
| Precipio Quarterly EPS | |
|---|---|
| 2025-06-30 | $0.05 |
| 2025-03-31 | $-0.59 |
| 2024-12-31 | $-0.22 |
| 2024-09-30 | $-0.42 |
| 2024-06-30 | $-0.83 |
| 2024-03-31 | $-1.46 |
| 2023-12-31 | $1.02 |
| 2023-09-30 | $-1.04 |
| 2023-06-30 | $-1.88 |
| 2023-03-31 | $-2.61 |
| 2022-12-31 | $-2.14 |
| 2022-09-30 | $-2.79 |
| 2022-06-30 | $-1.80 |
| 2022-03-31 | $-4.00 |
| 2021-12-31 | $-2.00 |
| 2021-09-30 | $-1.60 |
| 2021-06-30 | $-2.80 |
| 2021-03-31 | $-1.60 |
| 2020-12-31 | $6.80 |
| 2020-09-30 | $-4.20 |
| 2020-06-30 | $-4.00 |
| 2020-03-31 | $-15.60 |
| 2019-12-31 | $-9.80 |
| 2019-09-30 | $-6.20 |
| 2019-06-30 | $-21.00 |
| 2019-03-31 | $-9.60 |
| 2018-12-31 | $-38.80 |
| 2018-09-30 | $-49.80 |
| 2018-06-30 | $-45.80 |
| 2018-03-31 | $-142.00 |
| 2017-12-31 | $3,370.32 |
| 2017-09-30 | $-407.80 |
| 2017-06-30 | $-4,602.70 |
| 2017-03-31 | $-506.75 |
| 2016-12-31 | $-556.10 |
| 2016-09-30 | $-344.83 |
| 2016-06-30 | $-308.85 |
| 2016-03-31 | $-1,620.81 |
| 2015-12-31 | $-14,137.08 |
| 2015-09-30 | $-4,952.48 |
| 2015-06-30 | $-2,701.35 |
| 2015-03-31 | $-3,241.62 |
| 2014-12-31 | $-7,113.56 |
| 2014-09-30 | $-450.23 |
| 2014-06-30 | $-5,132.57 |
| 2014-03-31 | $-5,402.71 |
| 2013-12-31 | $-5,132.57 |
| 2013-09-30 | $-7,023.52 |
| 2013-06-30 | $-3,691.85 |
| 2013-03-31 | $-4,862.43 |
| 2012-12-31 | $-13,956.89 |
| 2012-09-30 | $-0.04 |
| 2012-06-30 | $-0.01 |
| 2012-03-31 | $-0.05 |
| 2011-12-31 | $-23,591.59 |
| 2011-09-30 | $-0.03 |
| 2011-06-30 | $-0.13 |
| 2011-03-31 | $-0.06 |
| 2010-12-31 | $-0.01 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.033B | $0.019B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.732B | 58.24 |
| Tempus AI (TEM) | United States | $12.524B | 0.00 |
| Doximity (DOCS) | United States | $11.721B | 48.51 |
| Hims & Hers Health (HIMS) | United States | $9.384B | 76.89 |
| IRhythm Technologies (IRTC) | United States | $5.716B | 0.00 |
| Hinge Health (HNGE) | United States | $3.454B | 0.00 |
| Privia Health (PRVA) | United States | $2.943B | 184.46 |
| Heartflow (HTFL) | United States | $2.876B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.435B | 40.29 |
| Enovis (ENOV) | United States | $1.624B | 8.53 |
| 10x Genomics (TXG) | United States | $1.618B | 0.00 |
| Omnicell (OMCL) | United States | $1.605B | 32.81 |
| Schrodinger (SDGR) | United States | $1.373B | 0.00 |
| Azenta (AZTA) | United States | $1.355B | 59.10 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Phreesia (PHR) | United States | $1.334B | 0.00 |
| Claritev (CTEV) | United States | $1.021B | 0.00 |
| Evolent Health (EVH) | United States | $0.705B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.683B | 0.00 |
| Talkspace (TALK) | United States | $0.568B | 113.00 |
| Butterfly Network (BFLY) | United States | $0.566B | 0.00 |
| Veradigm (MDRX) | United States | $0.545B | 0.00 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.402B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Carlsmed (CARL) | United States | $0.316B | 0.00 |
| TruBridge (TBRG) | United States | $0.289B | 13.27 |
| CapsoVision (CV) | United States | $0.225B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.220B | 0.00 |
| Outset Medical (OM) | United States | $0.210B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.208B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.186B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.183B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.171B | 0.00 |
| CareCloud (CCLD) | United States | $0.147B | 8.07 |
| EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.074B | 0.00 |
| American Well (AMWL) | United States | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.058B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.037B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |